Long-term follow-up of otherwise healthy term infants with marked hyperbilirubinaemia: should the limits of exchange transfusion be changed in Turkey?

Duman N., ÖZKAN H., Serbetcioglu B., Ogun B., Kumral A., Avci M.

ACTA PAEDIATRICA, vol.93, no.3, pp.361-367, 2004 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 93 Issue: 3
  • Publication Date: 2004
  • Doi Number: 10.1080/08035250310007475
  • Journal Name: ACTA PAEDIATRICA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.361-367
  • Keywords: bilirubin toxicity, brainstem auditory-evoked potentials, development, exchange transfusion, neonatal jaundice, NEONATAL HYPERBILIRUBINEMIA, BILIRUBIN, BRAIN, NEWBORN, GUIDELINES, JAUNDICE
  • Dokuz Eylül University Affiliated: Yes


Aim: To evaluate prospectively non-haemolytic term infants with marked hyperbilirubinaemia treated by phototherapy only for evidence of bilirubin toxicity at 2 - 6 y of age, and to determine the suitability for Turkish children of the exchange transfusion limits recently reported by the American Academy of Pediatrics. Methods: The study group included a total of 30 children, aged 2 - 6 y, who had developed marked hyperbilirubinaemia (20 - 24 mg dl(-1), 342 - 410 mumol l(-1)) during the newborn period (gestational age >37 wk, birthweight >2500 g) and were treated without exchange transfusion because intensive phototherapy, instituted during the preparations for exchange transfusion, was successful in decreasing their serum bilirubin levels. The control group consisted of 30 children of the same age group without clinical jaundice in the newborn period. Physical and neurological examinations, brainstem auditory-evoked potentials (BAEPs) and developmental tests for Turkish children were performed in both the study and control children. Results: There was no difference between the groups with regard to mean BAEP latencies and developmental scores. None of the infants had hearing loss, developmental delay or abnormal neurological findings.